Nissay Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.34M | Buy |
|
|||||
|
2025
Q1 | $1.66M | Buy |
|
|||||
|
2024
Q4 | $1.56M | Buy |
|
|||||
|
2024
Q3 | $1.61M | Buy |
|
|||||
|
2024
Q2 | $1.83M | Buy |
|
|||||
|
2024
Q1 | $1.87M | Buy |
|
|||||
|
2023
Q4 | $2.02M | Buy |
|
|||||
|
2023
Q3 | $1.79M | Buy |
|
|||||
|
2023
Q2 | $1.69M | Sell |
|
|||||
|
2023
Q1 | $1.93M | Sell |
|
|||||
|
2022
Q4 | $2.13M | Sell |
|
|||||
|
2022
Q3 | $1.75M | Buy |
|
|||||
|
2022
Q2 | $1.63M | Sell |
|
|||||
|
2022
Q1 | $1.52M | Buy |
|
|||||
|
2021
Q4 | $1.7M | Buy |
|
|||||
|
2021
Q3 | $1.44M | Buy |
|
|||||
|
2021
Q2 | $1.49M | Buy |
|
|||||
|
2021
Q1 | $1.32M | Sell |
|
|||||
|
2020
Q4 | $6.53M | Sell |
|
|||||
|
2020
Q3 | $6.64M | Buy |
|
|||||
|
2020
Q2 | $9.36M | Buy |
|
|||||
|
2020
Q1 | $4.93M | Buy |
|
|||||
|
2019
Q4 | $1.25M | Buy |
|
|||||
|
2019
Q3 | $969K | Buy |
|
|||||
|
2019
Q2 | $1.17M | Sell |
|
|||||
|
2019
Q1 | $1.24M | Buy |
|
|||||
|
2018
Q4 | $1.12M | Buy |
|
|||||
|
2018
Q3 | $1.22M | Buy |
|
|||||
|
2018
Q2 | $1.14M | Buy |
|
|||||
|
2018
Q1 | $934K | Buy |
|
|||||
|
2017
Q4 | $1.01M | Buy |
|